DRKS00030576尚未招募Unknown

Conventional partial pancreatoduodenectomy versus an extended pancreatoduodenectomy (triangle operation) for pancreatic head cancers – the randomized controlled TRIANGLE trial - TRIANGLE

Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Universitätsklinikum Tübingen0 个研究点目标入组 270 人开始时间: 2022年12月19日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Preoperative inclusion criteria:
•- Patients with suspected or histologically verified resectable, borderline or locally advanced pancreatic cancer of the pancreatic head (i.e. pancreatic ductal adenocarcinoma, IPMN (Intraductal Papillary Mucinous Neoplasms) carcinoma or periampullary cancer of the pancreatobiliary-type)
•- Patients scheduled for elective partial pancreatoduodenectomy (irrespective of neoadjuvant therapy)
•- Assumed resectability in accordance with the surgical protocol for experimental and control intervention as judged by the treating surgeon
•- Ability of subject to understand character and individual consequences of the clinical trial
•- Written informed consent
•- Age =18 years
•Intraoperative inclusion criteria (prior to randomisation):
•- No distant metastases
•- No paraaortic lymph node metastases
•- Intraoperative confirmation that the patient can be operated according to both surgical methods (experimental or control group)

•- Participation in another interventional trial with interference of intervention and outcome of this trial
•- American Society of Anesthesiologists (ASA) grade > 3
•- Distant metastatic disease

发起方

Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Universitätsklinikum Tübingen